
nm23A
geneN
encodeV
proteinN
thatDT
participateV
inP
tumorN
metastasisN
regulationN
andCC
variousA
fundamentalA
cellularA
processN
,PCT
althoughP
theirPP
mechanismN
ofP
actionN
beV
stillR
unknownA
.PCT
allDT
containV
nucleosideN
diphosphateN
(PCT
ndpN
)PCT
kinaseN
activityN
itPP
haveV
notR
establishV
thatP
theDT
enzymeN
mediateV
functionN
presentA
experimentN
wePP
examineV
effectN
onP
differentiationN
inductionN
systemN
humanA
leukemicA
cellN
includeV
hl-60A
u937A
hel/A
sN
ku812fN
k562N
helN
nativeA
erythrocyteN
inhibitV
erythroidA
ku812N
butCC
monocyticA
orCC
granulocyticA
hl-60N
SN
byP
recombinantA
nm23-h1N
-h2N
mouseN
nm23-m1N
-m2A
moreoverR
bothCC
mutantA
nm23-h2hisN
truncatedA
nm23-h2A
n-terminalA
@card@NUM
peptideN
whichDT
doV
ndpA
alsoR
theseDT
resultN
suggestV
1PCT
inhibitoryA
i-factor/A
restrictV
toP
m1A
2PCT
exhibitV
withoutP
speciesN
specificityN
3PCT
nm23/A
independentA
itsPP
requireV
presenceN
lipopolysaccharide-inducedA
e-selectinN
expressionN
continuousA
lpsN
bactericidal/A
permeability-increasingN
endothelialA
stimulateV
expressV
playV
anDT
importantA
roleN
neutrophilA
adhesionN
duringP
inflammationN
induceV
withinP
hN
peakN
atP
graduallyR
returnN
basalA
levelN
rbpi21A
aDT
fragmentN
bpiN
lps-inducedA
whenR
addV
sameA
timeN
asR
upR
6NUM
afterP
delayedA
administrationN
rbpi21N
affectV
lps-mediatedA
activationN
nuclearA
factorN
nf-kappaN
bPCT
twoNUM
4NUM
followV
additionN
alreadyR
activateV
resultV
markedA
reductionN
detectableA
indicateV
actN
reverseV
interruptV
on-goingA
signalV
gm-csfN
il-2N
shareN
commonA
controlN
responseN
costimulatoryA
signalN
tN
antigenN
complexedV
withP
majorA
histocompatibilityN
complexN
classN
iN
iiN
moleculeN
surfaceN
presentV
interactV
receptorN
tcrN
initiateV
cascadeN
soR
callV
otherA
interactionN
solubleA
cytokinesN
produceV
forP
completeA
highA
cytokineA
bothDT
granulocyte-macrophageN
colony-stimulatingN
sequenceN
promoterN
wellR
asP
powerfulA
enhancerN
locateV
3kbA
upstreamR
respondV
tcr-likeA
regionN
mainlyR
transcriptionN
nfatN
describeV
interleukin-2N
il-4A
suchA
cd28A
leadV
throughP
distinctA
thisDT
termV
ck-1N
cd28reN
appearV
bindN
specificA
memberN
familyN
leukemiaN
virusN
typeN
1NUM
htlv-1N
infectV
canV
increaseV
findV
htlv-1A
transactivatorN
taxN
actV
il-2A
cooperateV
ck-1/A
factor-kappaN
bindV
howeverR
coactivatorsN
remainV
identifyV
showV
degreeN
similarityN
il-3A
relatedA
observationN
togetherR
factN
respondN
viaP
implyV
conservationN
danazolN
decreaseN
estrogenN
monocyteN
overR
oneNUM
monthN
reduceV
erN
mrnaN
approximatelyR
%N
respectivelyR
alterV
degradationN
rateN
erA
decreaseV
run-onN
assayN
4PCT
mayV
releaseV
predominanceN
functionalA
characterizationN
novelA
transcriptionalA
inhibitorN
il-2-mediatedA
proliferationN
criticalA
earlyA
eventN
inflammatoryA
formationN
nfat-1A
essentialA
useV
lineN
stablyR
transfectedA
trimerN
regulatoryA
elementN
linkV
lac-zN
reporterN
screenV
nfat-1-mediatedA
beta-galactosidaseN
winV
micromN
compoundN
similarA
inhibitionN
observeV
secondA
scd8N
nfat-1-linkedA
transfectantsN
lymphocyteN
mixedA
reactionN
exogenousA
productionN
calcium-dependentA
pmaN
ionomycinN
pathwayN
converselyR
calcium-independentA
anti-cd28N
abN
pma-inducedA
resistantA
causeV
retardedA
mobilityN
gelN
criterionN
believeV
structurallyR
vacuolarA
h(+)-atpaseN
B2N
subunitN
differentiateV
thp-1A
monocyte-macrophageN
modelN
studyV
v-atpaseN
subunitsN
thp-1N
post-transcriptionalA
couldV
accountV
increaseN
contentN
fromP
runoffN
particularA
B2A
isoformN
MrN
=PCT
amplifyV
primarilyR
meanN
beginV
structureN
isolationN
sequenceV
firstA
exonN
5'-flankingA
revealV
tata-lessA
gN
+PCT
cPCT
primeA
extensionN
ribonucleaseN
protectionN
analysisN
singleA
startN
siteN
transfectedV
promoter-luciferaseA
plasmidsN
intoP
defineV
downstreamA
sufficientA
conferV
dnaseN
footprintingN
existenceN
multipleA
ap2N
sp1A
bindingA
5'-untranslatedA
proximalA
codeV
synergyN
betweenP
transductionN
obligatoryA
c-fosN
bN
:PCT
implicationN
immunoglobulinN
protooncogeneN
controlV
threeNUM
mainA
involveV
campN
calciumN
phosphorylationN
serumN
srfN
sreN
;PCT
crebN
presumablyR
calmodulin-regulatedA
BurkittN
'sPP
lymphomaN
ramosN
daudiN
lymphocyticA
jurkatN
stimulationN
anyDT
aloneR
littleA
noDT
combineV
eitherDT
forskolinN
plusCC
mixN
ionophoreN
greatlyR
enhancedA
contrastN
okadaicA
acidA
augmentN
pma-N
calcium-mediatedA
littleR
differenceN
stronglyR
synergisticA
ap-1A
shiftN
confirmV
requirementN
parallelV
dueA
anti-igN
releaseN
intracellularA
ourPP
needV
efficientA
sinceP
neitherDT
relevantA
supportV
camp-inducingN
agentN
furtherR
enhanceV
cell-specificA
patternN
featureN
csfN
mimicV
treatmentN
ca2+N
+34N
3NUM
kbN
cleoN
consistV
purine-richA
abutV
activatorN
protein-1N
-likeA
upstreamA
ck-1A
workN
mutationN
eitherCC
pma/A
ca2+A
620-bpA
promoter-N
luciferaseN
constructV
inducibleA
hcleoN
ap-1-likeA
showN
cyclosporin-sensitiveA
cyclosporinN
weakA
resembleV
nf-atN
ap-1N
nf-atpN
orderN
/PCT
allR
formV
eachDT
constitutivelyR
activeA
formN
calcineurinN
substituteV
synergizeN
mutant-activatedA
rasN
co-expressionN
additionalA
p65N
leastA
impingeV
il-10N
tyrosineN
tyk2N
jak1A
differentialA
assemblyN
stat1A
alphaN
stat3N
driveV
progressionN
immuneA
responsivenessN
suchDT
th2A
lymphocyte-mediatedA
predominateV
reportN
transducerN
mannerN
relativeA
homo-N
heterodimersN
varyV
il-10-stimulatedA
statN
m(rN
kdaN
recognizeV
anti-stat3N
il-10A
ligand-inducedA
jak2A
jak3A
selectiveA
modulationN
partN
pairN
useN
newA
biologicA
markerN
ovulationN
biologicalA
greatA
pastA
fallV
disuseN
largeA
diffusionN
biochemicalA
biophysicalA
oneN
realA
hormoneN
modificationN
targetN
tissueN
exploreV
reproductiveA
behaviourN
albuminemiaN
plateletN
ivN
indicatorN
aggregationN
estrogenicA
womanN
undergoV
themPP
9NUM
developV
lufN
syndromeN
constituteV
oppositeA
situationN
observedA
considerV
sufficientlyR
sensitiveA
amongP
mostR
reliableA
hormonalA
ovulatoryA
abnormalA
lprN
cd4-cd8-N
constitutiveA
cells-bindingN
inertA
qualityN
mrl-ipr/A
iprN
peripheralA
cd4-8-N
manifestV
inabilityN
proliferateV
mitogenicA
yetR
earlyR
tcr-mediatedA
generationN
inositolN
phosphateN
theyPP
displayV
p59fynN
cd3A
zetaN
messengerN
normallyR
